AAUTX
Price
$29.71
Change
+$0.38 (+1.30%)
Updated
Jun 6 closing price
Net Assets
2.6B
VIVIX
Price
$67.50
Change
+$0.66 (+0.99%)
Updated
Jun 6 closing price
Net Assets
188.77B
Interact to see
Advertisement

AAUTX vs VIVIX

Header iconAAUTX vs VIVIX Comparison
Open Charts AAUTX vs VIVIXBanner chart's image
Thrivent Large Cap Value A
Price$29.71
Change+$0.38 (+1.30%)
VolumeN/A
Net Assets2.6B
Vanguard Value Index I
Price$67.50
Change+$0.66 (+0.99%)
VolumeN/A
Net Assets188.77B
AAUTX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AAUTX vs. VIVIX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAUTX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. AAUTX (2.6B). VIVIX pays higher dividends than AAUTX: VIVIX (2.29) vs AAUTX (1.22). AAUTX was incepted earlier than VIVIX: AAUTX (26 years) vs VIVIX (27 years). AAUTX (0.84) is less costly to investors than VIVIX (0.04). AAUTX is a more actively managed with annual turnover of: 29.00 vs. VIVIX (9.00). AAUTX has a lower initial minimum investment than VIVIX: AAUTX (2000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 6.80 vs. AAUTX (1.81). VIVIX return over 5 years is better than : 58.67 vs. AAUTX (46.00).
AAUTXVIVIXAAUTX / VIVIX
Total Expense Ratio0.840.042,100%
Annual Report Gross Expense Ratio0.840.042,100%
Fund Existence26 years27 years-
Gain YTD3.8451.255306%
Front Load5%N/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.6B189B1%
Annual Yield % from dividends1.222.2953%
Returns for 1 year1.816.8027%
Returns for 3 years11.9818.5165%
Returns for 5 years46.0058.6778%
Returns for 10 years58.75102.8757%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OPTFX84.14N/A
N/A
Invesco Discovery Large Cap A
LMNOX40.71N/A
N/A
Patient Opportunity I
GCVIX23.39N/A
N/A
Goldman Sachs Large Cp Val Insghts Instl
LMCKX8.31N/A
N/A
Miller Income FI
SUSLX14.67N/A
N/A
Lazard US Sustainable Equity Open